Literature DB >> 21282

Stability of prostaglandin E1 and dinoprostone (prostaglandin E2) under strongly acidic and basic conditions.

R G Stehle, T O Oesterling.   

Abstract

The stability of prostaglandin E1 and dinoprostone was investigated at the extremes of the pH range (less than or equal to 3 and greater than or equal to 10) in the sequence prostaglandin E leads to prostaglandin A leads to prostaglandin B. The degradation rate is first order with hydrogen-ion and hydroxide-ion concentrations. Separation and analysis of the E prostaglandins were accomplished by TLC and UV spectrophotometry. At the lowest pH values and at elevated or low temperatures, significant amounts of 15-epiprostaglandin E were present. Apparent activation energies for the total dinoprostone loss, calculated from elevated temperature data, were 21 kcal/mole in the strongly acidic region and about 18 kcal/mole at pH 3. Corresponding studies in the alkaline region led to a derived arrhenius activation energy of 15 kcal/mole with the appearance of significant amounts of 8-isoprostaglandin E. This difference in activation energies may reflect the different mechanisms operant at high and low pH values.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21282     DOI: 10.1002/jps.2600661123

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Structural insights into human serum albumin-mediated prostaglandin catalysis.

Authors:  Jinsheng Yang; Charles E Petersen; Chung-Eun Ha; Nadhipuram V Bhagavan
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Quantitative determination of esterified eicosanoids and related oxygenated metabolites after base hydrolysis.

Authors:  Oswald Quehenberger; Signe Dahlberg-Wright; Jiang Jiang; Aaron M Armando; Edward A Dennis
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

3.  Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.

Authors:  David Palmero; Emilienne Chavan; Markoulina Berger-Gryllaki; Jean-François Tolsa; Ermindo R Di Paolo; André Pannatier; Hugues Henry; Farshid Sadeghipour
Journal:  Eur J Hosp Pharm       Date:  2017-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.